-
-
- R&D Unit
- Industrial Vaccine Production Unit
- Vaccine and Immunization Training Unit
- Vaccine Epidemiology Unit
- Preclinical and Clinical Research and Project Coordination Unit
- Epidemiology of Pandemic-Risk Infectious Agents Unit
- Bioterrorism Unit
- Laboratory Animal Production/Testing and Preclinical Research Unit
- Tissue Culture Collection, Viral and Bacterial Culture Banking Unit
- Quality Control Laboratory Unit
- Training, Administrative, and Financial Services Unit
-
-
-
- Announcements
- Key Dates
- FAQ
- Contact
Turkovac Clinical Trials Phase II
A placebo-controlled, randomized, double-blind, single-centre, Phase II clinical trial investigating the efficacy, immunogenicity, and safety of two different potencies of the inactive COVID-19 Vaccine ERUCOV-VAC, administered twice via the intramusc
Turkovac Clinical Trials Phase I
"A randomized, double-blind, national, single-centre, placebo-controlled Phase I clinical trial investigating the safety and immunogenicity of two different potencies of the inactive COVID-19 Vaccine ERUCOV-VAC, prepared in cell culture, administered